{
    "root": "2f88ad97-cf16-43f2-e063-6394a90a771b",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Losartan Potassium and Hydrochlorothiazide",
    "value": "20250304",
    "ingredients": [
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "LOSARTAN POTASSIUM",
            "code": "3ST302B24A"
        },
        {
            "name": "HYDROCHLOROTHIAZIDE",
            "code": "0J48LPH2TH"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        }
    ],
    "indications": "losartan potassium hydrochlorothiazide combination losartan , angiotensin ii receptor blocker ( arb ) hydrochlorothiazide , diuretic indicated : treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) reduction risk stroke patients hypertension left ventricular hypertrophy . evidence benefit apply black patients . ( 1.2 )",
    "contraindications": "hypertension usual starting dose : 50 mg/12.5 mg daily . ( 2.1 ) titrate needed maximum dose 100 mg/25 mg. ( 2.1 ) hypertensive patients left ventricular hypertrophy controlled monotherapy : initiate 50 mg/12.5 mg. titrate needed maximum 100 mg/25 mg. ( 2.2 )",
    "warningsAndPrecautions": "losartan potassium hydrochlorothiazide tablets usp , 100 mg/12.5 mg white , oval shaped , beveled edge , biconvex film-coated tablets debossed \u2018 f \u2019 one side \u2018 74 \u2019 side . ndc : 70518-2057-00 ndc : 70518-2057-01 packaging : 90 1 bottle plastic packaging : 90 1 bottle plastic store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) . [ usp controlled room temperature ] . keep container tightly closed . protect light . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "losartan potassium hydrochlorothiazide tablets contraindicated : \u2022 patients hypersensitive component product . \u2022 patients anuria \u2022 coadministration aliskiren patients diabetes",
    "indications_original": "Losartan potassium and hydrochlorothiazide is a combination of losartan, an angiotensin II receptor blocker (ARB) and hydrochlorothiazide, a diuretic indicated for: Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy. There is evidence that this benefit does not apply to Black patients. ( 1.2 )",
    "contraindications_original": "Hypertension Usual starting dose: 50 mg/12.5 mg once daily. ( 2.1 ) Titrate as needed to a maximum dose of 100 mg/25 mg. ( 2.1 ) Hypertensive Patients with Left Ventricular Hypertrophy Not controlled on monotherapy: Initiate with 50 mg/12.5 mg. Titrate as needed to a maximum of 100 mg/25 mg. ( 2.2 )",
    "warningsAndPrecautions_original": "Losartan Potassium and Hydrochlorothiazide Tablets USP, 100 mg/12.5 mg\u00a0are white, oval shaped, beveled edge, biconvex film-coated tablets debossed with \u2018F\u2019 on one side and \u201874\u2019 on the other side.\n                  \n                  NDC: 70518-2057-00\n                  NDC: 70518-2057-01\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  \n                  Store at\u00a020\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F). [See USP Controlled Room Temperature]. Keep container tightly closed. Protect from light.\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Losartan potassium and hydrochlorothiazide tablets are contraindicated: \n    \u2022\u00a0In patients who are hypersensitive to any component of this product. \n    \u2022\u00a0In patients with anuria \n    \u2022\u00a0For coadministration with aliskiren in patients with diabetes"
}